Cargando…
Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
BACKGROUND: Lymphopenia can decrease immune function of the host and is a known risk factor for poor prognosis in malignant tumors. Radiation induced lymphopenia was common in patients with breast cancer and was also reported to have a negative effect on long‐term outcome. AIMS: Lymphopenia may be a...
Autores principales: | Chen, Fang, Ma, Lingyu, Wang, Qian, Zhou, Manling, Nong, Yaqing, Jing, Haiman, Han, Ying, Liu, Yaya, Hu, Yulin, Yu, Hao, Fu, Pingfu, Kong, Feng‐Ming ( Spring) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327667/ https://www.ncbi.nlm.nih.gov/pubmed/34390318 http://dx.doi.org/10.1002/cnr2.1525 |
Ejemplares similares
-
Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy
por: Chen, Fang, et al.
Publicado: (2021) -
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022) -
Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022) -
Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
por: Zhang, Jinliang, et al.
Publicado: (2023) -
Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer
por: Yang, Li, et al.
Publicado: (2022)